Merck Introduces ChemiSphere® App for Enhanced Lab Data Access
Merck launches ChemiSphere® app for quick lab data access via 2D barcodes, enhancing efficiency and data integrity. 📱🔬
March 19, 2026
Follow us
latest articles
Discover the newest research about AI innovations in Research.
BioPathNet: A New AI Tool for Analyzing Biomedical Data Networks
BioPathNet is an AI tool for analyzing biomedical data networks, aiding in gene functions and disease mechanisms. 🧬🔍
March 19, 2026
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.
AI in CLL Research: 586 Patients Analyzed, 29.7% Started Treatment, 42.8% TP53 Aberrations. 📊💉
March 19, 2026
DiaCardia: AI Model for ECG-Based Prediabetes Detection
DiaCardia: An AI model detects prediabetes through ECG data, enabling non-invasive screening with wearable devices. 🩺📈
March 18, 2026
Safety and user perception of general-purpose large language models in pediatric healthcare: Evaluations of ChatGPT by doctors and parents.
Evaluating ChatGPT in Pediatric Healthcare: 73.2% accuracy, 80% parent clarity rating. Caution advised! 🤖👶📊
March 18, 2026
DHSC and NHSE Commit to £7.4 Billion Digital Investment by 2030
DHSC and NHSE plan a £7.4 billion investment in digital health by 2030. This aims to enhance technology and data use. 💻📈
March 18, 2026
Investigating Placebos and Controls Used in Large Language Model-Based Chatbot Intervention Trials: Protocol for a Methodological Review.
Exploring LLM Chatbot Trials: Control Conditions Matter! 🤖📊
March 18, 2026
Artificial Intelligence-enhanced Electrocardiography for Heart Failure Screening and Risk Stratification.
AI in ECG: Revolutionizing heart failure screening & risk stratification. Key findings from Dhingra et al. 📈❤️
March 18, 2026
Cyber Attack Disrupts NHS Medical Equipment Supply
Cyber attack impacts NHS medical equipment supply, affecting defibrillators and more. ⚠️🩺 Stay informed on healthcare disruptions.
March 17, 2026
Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets.
AI in High-Grade Glioma Treatment: 1648 MRI Sequences Analyzed, 15s Segmentation Time, Moderate Agreement with MDTB Diagnoses 📊🧠
March 17, 2026